Cargando…

Effect of Anti-Rheumatic Drugs on Cardiovascular Disease Events in Rheumatoid Arthritis

Rheumatoid arthritis (RA) is an autoimmune disease characterized by erosive arthritis, which can involve multiple systems. Patients with RA may have a variety of comorbidities, including cardiovascular disease (CVD), lung cancer, lymphoma, infection, osteoporosis, fatigue, depression, colon cancer,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baoqi, Yang, Dan, Ma, Xingxing, Zhao, Xueqing, Zhu, Yajing, Wang, Ke, Xu, Liyun, Zhang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8850698/ https://www.ncbi.nlm.nih.gov/pubmed/35187113 http://dx.doi.org/10.3389/fcvm.2021.812631

Ejemplares similares

Disease-modifying anti-rheumatic drugs improve the cardiovascular profile in patients with rheumatoid arthritis
por: Giachi, Andrea, et al.
Publicado: (2022)

Clinical application of mesenchymal stem cells in rheumatic diseases
por: Wang, Yajing, et al.
Publicado: (2021)

Patterns of Anti-Inflammatory and Immunomodulating Drug Usage and Microvascular Endothelial Function in Rheumatoid Arthritis
por: Mangoni, Arduino A., et al.
Publicado: (2021)

Related Risk Factors and Treatment Management of Psoriatic Arthritis Complicated With Cardiovascular Disease
por: Zheng, Zhoulan, et al.
Publicado: (2022)

Vascular Age, Metabolic Panel, Cardiovascular Risk and Inflammaging in Patients With Rheumatoid Arthritis Compared With Patients With Osteoarthritis
por: Rodríguez-Vargas, Gabriel-Santiago, et al.
Publicado: (2022)

Relationship between rheumatoid arthritis and cardiovascular comorbidity, causation or co-occurrence: A Mendelian randomization study
por: Wang, Min, et al.
Publicado: (2023)

Improvements in High-Density Lipoprotein Quantity and Quality Contribute to the Cardiovascular Benefits by Anti-tumor Necrosis Factor Therapies in Rheumatoid Arthritis: A Systemic Review and Meta-Analysis
por: Luo, Yonghong, et al.
Publicado: (2021)

Multifactorial intervention to prevent cardiovascular disease in patients with early rheumatoid arthritis: protocol for a multicentre randomised controlled trial
por: Svensson, Annemarie Lyng, et al.
Publicado: (2016)

Targeting Inflammation to Prevent Cardiovascular Disease in Chronic Rheumatic Diseases: Myth or Reality?
por: Bartoloni, Elena, et al.
Publicado: (2018)

Immunomodulatory effects of umbilical mesenchymal stem cell-derived exosomes on CD4(+) T cells in patients with primary Sjögren's syndrome
por: Ma, Dan, et al.
Publicado: (2023)

Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
por: Kobayashi, Masatake, et al.
Publicado: (2021)

Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Cardiovascular Risk in Patients With Rheumatoid Arthritis: A Cross-Sectional Study of Chinese Cohort
por: Zou, Yao-Wei, et al.
Publicado: (2022)

Periodontal Condition in Patients with Rheumatoid Arthritis: Effect of Anti-rheumatic Drugs
por: Kordtabar, Samira, et al.
Publicado: (2019)

Psoriatic Arthritis and Metabolic Syndrome: Is There a Role for Disease Modifying Anti-Rheumatic Drugs?
por: Atzeni, Fabiola, et al.
Publicado: (2021)

PCSK9/LDLR System and Rheumatoid Arthritis-Related Atherosclerosis
por: Arida, Aikaterini, et al.
Publicado: (2021)

Sex-Specific Association of Left Ventricular Hypertrophy With Rheumatoid Arthritis
por: Giollo, Alessandro, et al.
Publicado: (2021)

Association Between Circulating Retinol-Binding Protein 4 and Adverse Cardiovascular Events in Stable Coronary Artery Disease
por: Qian, Ke, et al.
Publicado: (2022)

Population-based assessment of cardiovascular complications of rheumatic heart disease in Fiji: a record-linkage analysis
por: Parks, Tom, et al.
Publicado: (2023)

The rise and fall of acute rheumatic fever and rheumatic heart disease: a mini review
por: Liang, Yunmei, et al.
Publicado: (2023)

Protocol for a population-based study of rheumatic heart disease prevalence and cardiovascular outcomes among schoolchildren in Nepal
por: Pilgrim, Thomas, et al.
Publicado: (2012)

Effect of Exercise Prescription Implementation Rate on Cardiovascular Events
por: Zhu, Li-Yue, et al.
Publicado: (2022)

Rheumatoid arthritis and coronary atherosclerosis: a two-sample Mendelian randomization study
por: Nie, Qiong, et al.
Publicado: (2023)

A Meta-Analysis Evaluating the Effectiveness and Safety of Upadacitinib in Treating Rheumatoid Arthritis in Patients With Inadequate Response to Disease-Modifying Anti-Rheumatic Drugs
por: Panchal, Viraj, et al.
Publicado: (2023)

Regulatory T Cell Suppressive Activity Predicts Disease Relapse During Disease-Modifying Anti-rheumatic Drug Dose Reduction in Rheumatoid Arthritis: A Prospective Cohort Study
por: Kanjana, Korawit, et al.
Publicado: (2020)

Rheumatic heart disease: pilot study for a population-based evaluation of prevalence and cardiovascular outcomes among schoolchildren in Nepal
por: Shrestha, Nikesh Raj, et al.
Publicado: (2012)

Establishing Classification Tree Models in Rheumatoid Arthritis Using Combination of Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry and Magnetic Beads
por: Ma, Dan, et al.
Publicado: (2021)

Wildfire smoke exposure and cardiovascular disease—should statins be recommended to prevent cardiovascular events?
por: Vuorio, Alpo, et al.
Publicado: (2023)

Transcatheter Valve-in-Valve Procedures for Bioprosthetic Valve Dysfunction in Patients With Rheumatic vs. Non-Rheumatic Valvular Heart Disease
por: Lopes, Mariana Pezzute, et al.
Publicado: (2021)

Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis
por: Zhao, Sizheng Steven, et al.
Publicado: (2022)

Effects of a 12-week cardiovascular rehabilitation programme on systemic inflammation and traditional coronary artery disease risk factors in patients with rheumatoid arthritis (CARDIA trial): a randomised controlled trial
por: Heinze-Milne, Stefan, et al.
Publicado: (2017)

Expanding Valve Repair in Rheumatic Heart Disease
por: Afifi, Ahmed, et al.
Publicado: (2022)

Examining anti-inflammatory therapies in the prevention of cardiovascular events: protocol for a systematic review and network meta-analysis of randomised controlled trials
por: Boczar, Kevin Emery, et al.
Publicado: (2022)

Gout, Rheumatism, and Rheumatoid Arthritis
Publicado: (1900)

Chronic Rheumatism and Rheumatoid Arthritis
por: Lindsay, J.
Publicado: (1908)

Anti-inflammatory Nanomedicine for Cardiovascular Disease
por: Katsuki, Shunsuke, et al.
Publicado: (2017)

Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials
por: Gong, Chen, et al.
Publicado: (2022)

Baseline and Cumulative Blood Pressure in Predicting the Occurrence of Cardiovascular Events
por: Zuo, Yingting, et al.
Publicado: (2021)

Rheumatic Heart Valve Disease Pathophysiology and Underlying Mechanisms
por: Passos, Livia S. A., et al.
Publicado: (2021)

Household Economic Consequences of Rheumatic Heart Disease in Uganda
por: Opara, Chinonso C., et al.
Publicado: (2021)

Plasma osteoprotegerin predicts adverse cardiovascular events in stable coronary artery disease: the PEACE trial
por: Ma, Teng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sqphhn1kghmm3gplnolrn9i5cg